Lemonade, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
John Sheldon Peters, Chief Insurance Officer of Lemonade, Inc., received 10,000 shares of common stock on July 27, 2026.
NYSE
Lemonade's Chief Financial Officer, Timothy E. Bixby, has sold a significant number of shares under a pre-arranged trading plan.
NYSE
Lemonade, Inc. Chief Insurance Officer John Peters sold 3,444 shares of common stock for $77,942 under a pre-arranged trading plan.
NYSE
Director Michael Eisenberg reported a gift of 5,000 shares of Lemonade, Inc. common stock.
NYSE
Lemonade, Inc. CFO Timothy Bixby sold 2,227 shares of common stock to satisfy tax withholding obligations related to RSU vesting.
NYSE
John Peters, Chief Insurance Officer of Lemonade, Inc., sold a total of 5,343 shares of common stock across two transactions.
NYSE
Chief Business Officer Maya Prosor sold 1,220 shares of Lemonade, Inc. to satisfy tax withholding requirements related to RSU vesting.
NYSE
Director Geoff Seeley was granted 2,848 restricted stock units in Lemonade, Inc. as part of his compensation.
NYSE
Lemonade, Inc. director Prashant Ratanchandani was granted 2,848 restricted stock units as part of his compensation.
NYSE
Lemonade, Inc. director Debra Schwartz was granted 2,848 restricted stock units as part of an equity compensation award.
NYSE
Director Samer Haj-Yehia was granted 2,848 restricted stock units in Lemonade, Inc. as part of his compensation.
NYSE
Director Maria Angelidis-Smith was granted 2,848 restricted stock units in Lemonade, Inc. as part of an equity award.
NYSE
Lemonade director Maria Angelidis-Smith reported open‑market share purchases and corrected the original Form 4 to show Transaction Code “P.”
NYSE
Lemonade's President, Shai Wininger, was granted 1 million restricted stock units, including 180,000 performance-based units tied to a $110 stock price target.
NYSE
Lemonade, Inc. CEO Daniel Schreiber received significant equity awards, including 820,000 restricted stock units and 180,000 performance-based restricted stock units, vesting over several years.
NYSE
Lemonade Director Maria Angelidis-Smith acquired 8,740 shares of common stock for approximately $485,000, increasing her beneficial ownership in the company.
NYSE
Lemonade's Chief Financial Officer, Timothy Bixby, sold 2,135 shares of common stock at $50.12 per share to cover tax withholding obligations related to RSU vesting.
NYSE
Lemonade's Chief Insurance Officer, John Sheldon Peters, reported sales of common stock totaling 5,344 shares in early March 2026.
NYSE
Lemonade's Chief Business Officer, Maya Prosor, sold 223 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
Lemonade CEO Daniel Schreiber sold 9,108 shares of common stock for $99.04 per share under a Rule 10b5-1 trading plan.
NYSE
Lemonade Inc. CEO Daniel A. Schreiber sold 126,625 shares of common stock for $94.74 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Lemonade's Chief Insurance Officer, John Sheldon Peters, sold 9,000 shares of common stock for $90 per share, reducing his direct beneficial ownership to 70,228 shares.
NYSE
Lemonade's Chief Insurance Officer, John Sheldon Peters, exercised stock options for 18,457 shares of common stock at $5.26 per share.
NYSE
Lemonade's Chief Insurance Officer, John Sheldon Peters, sold 10,000 shares of common stock for $80 per share, reducing his direct beneficial ownership to 60,771 shares.
NYSE
Lemonade, Inc.'s Chief Operating Officer, Adina Eckstein, sold 7,919 shares of common stock for $84.15 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Lemonade Director Debra Schwartz sold 4,200 shares of common stock for $83.59 per share under a Rule 10b5-1 trading plan.
NYSE
Lemonade's Chief Operating Officer, Adina Eckstein, sold 7,919 shares of common stock for $81.15 per share as part of a pre-arranged trading plan.
NYSE
Lemonade's Chief Insurance Officer, John Sheldon Peters, reported a pre-planned sale of 3,554 shares of common stock at $81 per share, effective December 10, 2025.
NYSE
Lemonade's Chief Operating Officer, Adina Eckstein, exercised stock options and subsequently sold a significant number of common shares under a pre-arranged 10b5-1 trading plan.
NYSE
Lemonade Inc.'s Chief Financial Officer, Timothy E. Bixby, sold 2,862 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.